Oxford Biomedica and Sigma-Aldrich win key ruling in open biosystems patent infringement dispute
Oxford BioMedica and Sigma-Aldrich announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich. The ruling was part of the construction of patent claim terms in the patent infringement suit brought against Open Biosystems, Inc.
The lawsuit, which is pending in the U.S. District Court for the Eastern District of Missouri, alleges that Open Biosystems infringes U.S. Patent Nos. 6,924,123 and 7,056,699 entitled Lentiviral LTR Deleted Vector, which are owned by Oxford BioMedica and exclusively licensed to Sigma-Aldrich for research use, by selling, among other products, Open Biosystems' Lentiviral shRNAmir Library. In his order U.S. District Judge Charles A. Shaw concluded "that the constructions of the disputed terms and phrases proposed by plaintiff are correct."
Most read news
Organizations
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Low-carb diets linked to atherosclerosis and impaired blood vessel growth - Study suggests that popular diet regimen may have adverse effect on body's restorative capacity
Drug that modifies gene activity could help some older leukemia patients
Illumina and Wellcome Trust Sanger Institute Announce Completed Genome for Endangered Tasmanian Devil - Uncovering Mutations Found in Deadly Transmissible Cancer Could Help Conservation Efforts

Genetic enigma solved - Inheritance of coat color patterns in dogs

A molecular map for the plant sciences - First comprehensive map of the proteome of the model plant Arabidopsis thaliana
Flying with fuel from sugarcane - A new promising biofuel feedstock
Thomson Reuters Predicts Nobel Laureates

How resistant cancer cells can be fought
Thermo Fisher Scientific Continues Investment in Global Manufacture of Bioprocessing Products - New Manufacturing Line in China Expands Production Capacity of Leading Thermo Scientific Bioprocessing Products in Europe, North America and Asia-Pacific

Can we promote healthy ageing of our cells? - The "firefighter" protein calls for the degradation of defective proteins
